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Here we show that marginal zone (MZ)-B cells in rats can already be detected in neonatal spleen from
two days after birth. At this time point, morphologically distinct MZs are not present yet and the vast
majority of B cells in spleen are located in a concentric area surrounding the T cell zones (PALS).
Before MZs are obviously detectable in spleen (14 days after birth), MZ-B cells seem to be enriched at
the outer zones of the concentric B cell areas. Similar to adult rats, neonatal MZ-B cells are
intermediate-sized cells that express high levels of surface (s)IgM and HIS57 antigen, and low levels of
sIgD and CD45R (HIS24). We show here, however, that in contrast to adult MZ-B cells, MZ-B cells
(and also recirculating follicular (RF)-B cells) in neonatal rats express higher levels of CD90 (Thy-1).
In adult rats, expression of CD90 on the B cell lineage is conﬁned to immature B cells. We speculate
that the expression of CD90 on neonatal MZ-B cells may have implications for their responsiveness to
polysaccharide (T cell-independent type 2) antigens.
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INTRODUCTION
In mammals, splenic marginal zone (MZ)-B cells are
functionally implicated in the antibody (Ab) response
against bloodborn micro-organisms, especially against
encapsulated bacteria like Streptococcus pneumoniae,
Neisseria meningitidis and Haemophilus inﬂuenzae
(MacLennan and Liu, 1991; Spencer et al., 1998). The
capsules of these bacteria consist of polysaccharides
which characteristically elicit T cell-independent type 2
(TI-2) Ab responses upon infection (Mosier and Subbarao,
1982; Mond et al., 1995). Experiments in mice revealed
that survival from infection with encapsulated bacteria
strongly correlates with the ability of the host to mount a
rapid anti-polysaccharide Ab response (Peltola et al.,
1977; Feeney et al., 1996; Guo et al., 1997; Benedict and
Kearney, 1999).
In humans, responsiveness to TI-2 antigens does not
develop until several months after birth and does not reach
adult levels until after 5 years of age (Pabst and Kreth,
1980; Rijkers et al., 1998). This might be one of the
reasons that explains the high incidence of death resulting
from infection with encapsulated bacteria in young
children. A similar phenomenon is observed in mice,
where responsiveness to TI-2 antigens also appears to
develop relatively late in ontogeny (Mosier et al., 1977).
In addition to the immaturity of macrophages and
the rather low serum levels of many components of the
complement pathway (especially components of the
alternative pathway) (Pabst and Kreth, 1980), the weak
TI-2 antibody responses in neonates and young children
may well result from the absence and/or immaturity of the
splenic MZ-B cells at childhood (Timens et al., 1989;
Rijkers et al., 1998; Zandvoort et al., 2001a). In both
human and rodent spleen, B cell follicles and MZs have
not yet developed at birth (Friedberg and Weissman,
1974; Dijkstra and Dopp, 1983; Kroese et al., 1987;
Timens et al., 1989). Dijkstra and Dopp, 1983 showed
by immunohistology using polyclonal Abs that MZ-B
cells in rats can be phenotypically distinghuished in the
spleen as early as 6 days after birth. At this time, B cells
are found in spleen in a concentric ring surrounding the
periarteriolar lymphoid shealth (PALS). B cells located at
the outermost border of these concentric areas, exhibit a
strong membrane staining for IgM. Dijkstra and Dopp,
1983 suggested that these IgM
high cells likely represent
MZ-B cells.
Several studies have provided evidence that MZ-B cells
have a mixed origin and may contain “naive” (non-
memory) B cells as well as memory B cells. In human
adults, most MZ-B cells are memory B cells, as is
concluded from the somatic mutations found in
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(VH) genes of human MZ-B cells (Dunn-Walters et al.,
1995; Tierens et al., 1999). In addition, most MZ-B cells
in man express the memory B cell marker CD27 (Tangye
et al., 1998). In adult mice and rats, however, most MZ-B
cells express germline encoded Ig VH genes, indicating
that the vast majority of MZ-B cells in the spleen of these
species consist of non-memory B cells (Makowska et al.,
1999; Dammers et al., 2000). Similarly, very few memory
B cells are found in human spleens at birth, as is illustrated
by the fact that only very few MZ-B cells express CD27 at
that time (Zandvoort et al., 2001a). We, and others
demonstrated that the non-memory MZ-B cells can arise
directly from mature RF-B cells without the requirement
for proliferation (MacLennan and Liu, 1991; Dammers
et al., 1999). In addition, we recently showed that MZ-B
cells in normal adult rats display a selected Ig repertoire
(Dammers et al., 2000), which is most likely the result of
positive selection constrains (Martin and Kearney, 2000).
If the MZ-B cell selection constrains are different during
ontogeny, this might well be a possible explanation for the
lack of responsiveness to TI-2 antigens in early
mammalian life, because it would lead to a different and
perhaps for TI-2 antigens less adapted Ig repertoire.
To address issues related to the selection process of MZ-
B cells, we ﬁrst studied the neonatal development of
MZ-B cells in rats, in terms of phenotype and
immunohistological localization in vivo. Here, we show
that MZ-B cells can already be detected by ﬂow cytometry
and immunohistology by two days after birth. Further-
more, for at least the ﬁrst three weeks after birth, neonatal
MZ-B cells were found to express intermediate levels of
the “immature B cell marker” CD90.
RESULTS
Flow Cytometry Analysis Reveals the presence of
Splenic MZ-B Cells already Two Days after Birth
In order to study MZ-B cell development in neonatal
rats, spleen cell-suspensions were prepared from 2-, 10-,
14- and 21-days old animals and analyzed by three-color
ﬂow cytometry. MZ-B cells can be detected in adult spleen
by virtue of their unique phenotype: MZ-B cells are
sIgM
highsIgD
lowCD45R
lowCD90
neg and express high
levels of an antigen recognized by the newly developed
mAb HIS57 (Dammers et al., 1999). In adult rat spleen,
staining forIgMandIgD reveals thepresenceoftwo Bcell
subsets: sIgM
lowsIgD
high and sIgM
highsIgD
low B cells,
both of which can be further subdivided by virtue of CD90
expression levels. The sIgM
lowsIgD
high B cell subset
comprise early recirculating follicular (ERF)-B cells
(CD90
high) and recirculating follicular (RF)-B cells
(CD90
neg), whereas the sIgM
highsIgD
low B cell subset
contains newly formed (NF)-B cells (CD90
high) and MZ-B
cells (CD90
neg) (Kroese et al., 1995). Figure 1 shows that
sIgM
highsIgD
low B cells predominate in spleen during
the ﬁrst three weeks after birth. Two days after birth, the
percentage of sIgM
highsIgD
low B cells is about four times
higher than the percentage of sIgM
lowsIgD
high B cells,
whereas in adult rats there are generally about two times
more sIgM
lowsIgD
high B cells than sIgM
highsIgD
low
B cells. Figure 1 also shows that, in contrast to adult
animals, all IgM/IgD-deﬁned neonatal B cells express
intermediate or high levels of CD90, whereas CD90
neg
cells are virtually absent. Two days after birth, about 50%
FIGURE 1 Flow cytometry analysis of neonatal rat spleen stained
for IgM, IgD and CD90. Spleens were taken 2, 10 and 21 days after birth
and from adult rats (5-months-old). In adult rat spleen, the
sIgM
highsIgD
low B cell subset consists of NF-B cells (CD90
high)
and MZ-B cells (CD90
neg), and the sIgM
lowsIgD
high B cell subset
consists of ERF-B cells (CD90
high) and RF-B cells (CD90
neg). Note the
presence of cells that express intermediate levels of CD90 and the
virtual absence of CD90
neg cells within the IgM/IgD-deﬁned B cell
subsets during neonatal spleen development. Contour plots
(5% probability) were generated on the basis of 40,000 events, after
gating for lymphoid cells on the basis of forward-sideward scatter
proﬁles. Numbers representpercentages within the lymphoid gate, except
for CD90 where numbers represent percentage of cells within the
respective IgM/IgD gate.
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highsIgD
low B cells express high levels
of CD90 and therefore represent NF-B cells (Fig. 1).
As shown in Fig. 2, the absolute number of NF-B cells in
neonatal spleen already reaches adult levels by 14 days
after birth. At weaning (day 21), the number of NF-B cells
in spleen exceeds that of adult rats by two-fold. The other
sIgM
highsIgD
low neonatal B cells express intermediate
levels of CD90, a phenotype that is not seen in adult
animals. These neonatal sIgM
highsIgD
lowCD90
int cells are
most probably MZ-B cells. MZ-B cells in adult rats
express low levels of CD45R (HIS24) and high levels of
HIS57 antigen. As we show in Fig. 3, cells with such a
phenotype are also seen in neonatal spleens. Already two
days after birth, low numbers of sIgM
highHIS57
high and
sIgM
highCD45R
low MZ-B cells can be distinguished.
Consistent with a MZ-B cell phenotype, these cells are
relatively large, as revealed by their higher forward-scatter
proﬁle, compared to other B cells in spleen. Furthermore,
we show that neonatal MZ-B cells deﬁned by staining for
sIgM in combination with CD45R (HIS24) or HIS57
antigen, express intermediate levels of CD90. The CD90
expression levels are the highest on MZ-B cells taken
from spleens two days after birth and these levels
gradually diminish with age. Absolute numbers of MZ-B
cells increase more than 10-fold during the ﬁrst three
weeks of life (Fig. 2).
During the ﬁrst threeweeks after birth, the vast majority
of the sIgM
lowsIgD
high B cells express relatively high
levels of CD90 and likely represent ERF-B cells (Fig. 1).
In adult rats, ERF-B cells constitute only a relatively small
proportion of sIgM
lowsIgD
high B cells. The other B cells
belonging to the sIgM
lowsIgD
high subset, express inter-
mediate levels of CD90. The expression levels of CD90 on
these cells diminish gradually over time. We speculate
here that the IgM
lowsIgD
highCD90
int B cells may well
represent RF-B cells that express some CD90, similar to
MZ-B cells. Indeed, numbers of sIgM
lowsIgD
highCD90
int
B cells increase with age (Fig. 2), which can be expected
for the expanding RF-B cell pool.
Figure 4 shows that two days after birth, appreciable
numbers of sIgM
negCD90
highCD24
high cells can be
detected in rat spleen. In adult bone marrow these cells
represent pro/pre-B cells (Hermans et al., 1997).
This observation indicates that, in addition to bone
marrow, B lymphopoiesis also takes place in the neonatal
spleen. The pro/pre-B cells in spleen probably contribute
to a rapid generation of NF-B cells only during the ﬁrst
week of life, because splenic pro/pre-B cells are virtually
absent by 10 days of age.
Immunohistochemical Staining Reveals the presence of
MZ-B Cells in Neonatal Animals
In order to study the in situ development of MZ and MZ-B
cells in neonatal rat spleen, we stained serial frozen
section of 2-, 10-, 14- and 21-days-old spleen for either
IgM, IgD, Igk, TCRab, CD45R (HIS24), CD90 or HIS57
antigen. Two days after birth, small numbers of TCRþ
ab
T cells are found in spleen which are predominantly
located in an area around the central arterioles (PALS).
At this age, most IgM
þ B cells reside in a distinct
concentric area surrounding the PALS (Fig. 5). B cells
located at the outermost border of these concentric areas
exhibit more (membranous) IgM staining compared to
B cells of the inner part. In addition to B cells in these
concentric areas, small numbers of IgM
þ B cells and
IgM
þ plasma cells can also be detected scattered
throughout the red pulp. Two days after birth, the vast
majority of IgM
þ B cells in spleen seem to express Igk
light-chains, since the number of Igk
þ and IgM
þ cells as
well as the staining patterns for either IgM and Igk are
very similar. Figure 5 shows that only a fraction of the
B cells in the concentric areas surrounding the PALS
express IgD. A similar fraction also stains for CD45R
FIGURE 2 Absolute numbers of NF-B, ERF-B, RF-B and MZ-B cells in spleen of neonatal PVG rats (2, 10, 14 and 21 days after birth) and adult
rats (5-months-old). B cell subsets were determined by means of three-color ﬂow cytometry using anti-IgM, anti-IgD and anti-CD90 staining (see text).
For neonatal animals, RF-B and MZ-B cells were deﬁned as CD90
int/neg cells (within the respective IgM/IgD gate). For each time point, the absolute
number of cells per subset is the average of three animals, except for the adult ðn ¼ 4Þ: Error bars represent the standard deviation (SD).
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P.M. DAMMERS et al. 190(HIS24) (data not shown). IgD
þ and CD45R
þ (HIS24)
cells are enriched at the inner part of the concentric areas,
and may well represent follicular type B cells (ERF-B and
RF-B). Also in the red pulp some scattered CD45R
þ
(HIS24) cells are found (approximately in equal numbers
as IgM
þ cells), whereas only limited numbers of IgD
þ
cells are present in this area. In addition to numerous cells
in the red pulp, virtually all B cells in the concentric areas,
stain for CD90. HIS57 staining was not observed in two-
days-old spleen (data not shown).
While at day 10 after birth most B cells are still conﬁned
to the concentric areas surrounding the PALS, some initial
FIGURE 4 Flow cytometry analysis showing the presence of pro/pre-B cells in two-days-old rat spleen. Neonatal (day 2 and 10) and adult (5-months-
old) spleen cells as well as adult bone marrow cells were stained for IgM, CD90 and CD24. Shown is the CD90 vs. CD24 expression pattern for sIgM
neg
cells. Dotplots were established on the basis of 40,000 events after gating for lymphoid cells using forward–sideward scatter proﬁles. Numbers represent
percentages within the lymphoid gate. Note the presence of appreciable numbers of CD90
highCD24
high cells (pro/pre-B cells) among the sIgM
neg spleen
cells two days after birth.
FIGURE5 Indirectimmunoperoxidase stainingwith anti-IgM(HIS40) andanti-IgD(MaRD3) of serial frozensectionsof rat spleen2 and 10 days after
birth. At these time points, B cells are located in concentric areas surrounding the T cell areas (PALS); distinct B cell follicles and MZs are not present
yet. Note that cells with the strongest membranous IgM staining are enriched at the outer zone of the concentric B cell areas, whereas IgD staining is
conﬁned to the inner parts.
ONTOGENY OF MARGINAL ZONE B CELLS 191follicle development is seen and a marginal sinus can
sometimes be distinguished (Fig. 5). At this age, follicular
type B cells (IgM
þ, IgD
þ and CD45R
þ) reside primarily
in the inner parts of the concentric B cell areas. Cells in the
outermost border of the concentric B cell areas display a
strong membranous IgM and a weak HIS57 staining, but
are IgD
low/neg and CD45R
low/neg (Fig. 5; data for HIS57
and CD45R not shown). The phenotype of these cells is
typical for MZ-B cells. Thus, although follicles and MZ
are not yet clearly developed in 2–10-days-old spleens,
their characteristic B cells appear to be present already and
somehow spatially separated from each other.
From 14 days after birth, B cell follicles and MZ are
clearly recognized in spleen. Two-color indirect immuno-
ﬂuorescent staining (Fig. 6) of 14-days-old spleen shows
that most B cells located in the MZ express high levels of
HIS57 antigen and only low levels of CD45R (HIS24), and
thus represent typical MZ-B cells. On the other hand, most
B cells present in follicles exhibit strong CD45R (HIS24)
staining and are virtually negative for HIS57 antigen.
Therefore, these cells represent typical follicular type of
B cells. Although most follicular B cells in both neonatal
and adult rat spleen are CD45R
highHIS57
low/neg,F i g .6
shows that a minority of the follicular B cells stain negative
or weakly for CD45R (HIS24) but strongly for HIS57
antigen. These CD45R
low/negHIS57
high follicular B cells are
predominantly conﬁned to the outer zone of the follicles.
We also observed that B cells in this region of the follicles
frequently stain strongly for IgM and weakly for IgD (data
not shown). Therefore, these follicular B cells resemble
phenotypically MZ-B cells. We currently do not know
whether these cells are MZ-B cells, immediate MZ-B pre-
cursor cells or represent a novel (follicular) B cell subset.
DISCUSSION
Our study shows that already two days after birth, small
numbersofMZ-Bcellscanbedetectedinratspleenbyﬂow
cytometry. Similar to adult rats, these neonatal MZ-B cells
are intermediate-sized sIgM
highsIgD
low cells that express
relatively low levels of CD45R (HIS24) and relatively high
levels of HIS57 antigen. During the ﬁrst 10 days after birth,
however, immunohistologically deﬁned MZ and follicles
have not yet developed. In this period most splenic B cells
reside in a distinct concentric area surrounding the PALS.
DespitethelackofamorphologicallydistinctMZ,bothMZ
type and follicular type of B cells are present in neonatal
spleen. MZ-B cells are enriched at the outermost border of
the concentric areas, since cells located here exhibit strong
membranous staining for IgM and are virtually negative
for both IgD and CD45R (HIS24). Follicular B cells
(ERF and RF B cells), on the other hand, are enriched
at the inner part of the concentric areas, as the majority
of cells at this location, stain for IgM, IgD and CD45R
(HIS24). Our data therefore indicate that MZ-B cells
appear earlier in ontogeny than initially described in
the(immunohistological)studyofDijkstraandDopp,1983.
Inneonatalspleen,NF-Bcellsare locatedinthe redpulp,as
manycellsinthisareastainforIgMandCD45R(HIS24),but
not for IgD. We cannot, however, rule out completely the
possibilitythat(some)NF-Bcells(IgM
þIgD
2CD45R
þ)are
also present in the concentric B cell areas.
Neonatal MZ-B cells display some subtle phenotypic
differences with adult MZ-B cells. First, ﬂow cytometry
reveals that levels of HIS57 antigen on two-days-old
MZ-B cells are about ﬁve times lower compared to adult
rats. This lower expression level may explain the absence
of HIS57 staining of spleen sections from two-days-old
rats. Whether the lower HIS57 antigen expression levels
have functional implications, awaits further characteriz-
ation of the HIS57 antigen. Second, our study also shows
that, in contrast to adult rats, neonatal MZ-B cells and
RF-B cells express CD90 (Thy-1). CD90 is a heavily
glycosylated, glycosyl phosphatidylinositol (GPI)
anchored surface protein which is abundantly expressed
on rodent thymocytes and mammalian neurons (Crawford
and Barton, 1986; Firer et al., 1995; Killeen, 1997).
In adult rats, CD90 is also expressed on the surface of
immature B cells (pro/pre-B, NF-B, and ERF-B), but is
almost completely absent from RF-B and MZ-B cells.
(Crawford and Goldschneider, 1980; Kroese et al., 1995).
Levels of CD90 on neonatal MZ-B cells diminish
gradually with age; by three weeks after birth, these
levels are still higher compared to adult MZ-B cells.
The expression of this molecule on neonatal MZ-B cells
may suggest that neonatal MZ-B cells are still immature.
CD90 expression on neonatal RF-B and MZ-B cells is
either due to active regulation of CD90 gene transcription
or may reﬂect the fact that the vast majority of RF-B and
MZ-B cells in neonatal animals are recently generated
cells in which CD90 is not completely lost by turnover.
Timens et al., 1989 and Zandvoort et al., 2001a
suggested that the lack of responsiveness to TI-2 antigens
in early childhood (Pabst and Kreth, 1980; Rijkers et al.,
1998) is probably due to the immaturity of the splenic
MZ-B cells in ﬁrst two years of human life. This
conclusion was based on their observation that splenic
MZ-B cells of newborns lack, or weakly express, CD21
(CR2). We like to speculate here that the expression of
CD90 on neonatal rat MZ-B cells might also have
implications for their ability to respond to TI-2 antigens.
Experiments with CD90-deﬁcient (Thy-1
2/2) mice have
demonstrated that CD90 negatively regulates (inhibits)
TCR-mediated signaling in thymocytes (Hueber et al.,
1997). A similar inhibitory function of CD90 is also
observed in neurons, where ligation of surface CD90
suppresses the outgrowth of neurites (Tiveron et al.,
1992). Thus, CD90 could also play an inhibitory role in
B cell receptor (BCR) signaling and therefore negatively
affect B cell responsiveness to TI-2 antigens.
In mice, MZ-B and B-1 cells share several phenotypic
and functional characteristics, but differ, however, with
respect to their developmental origin and anatomical
location (Martin and Kearney, 2001). In contrast to splenic
MZ-B cells, B-1 cells are self-replenishing and are
P.M. DAMMERS et al. 192F
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ONTOGENY OF MARGINAL ZONE B CELLS 193enriched in coelomic (peritoneal and pleural) cavities.
There are no indications that MZ-B cells can become B-1
cells and vice versa. So far, we have not unequivocally
detected the homologue of murine B-1 cells in the rat
(Vermeer et al., 1994). However, in a previous study,
we observed a novel, previously unidentiﬁed B cell
subset in the peritoneal cavity of SCID mice, reconstituted
with rat fetal liver cells (rat ! SCID mouse chimeras)
(Deenen et al., 1997). Flow cytometry analysis
of these peritoneal rat-derived cells revealed the
following phenotype: sIgM
highCD45R
lowHIS57
high
CD90
int. We speculated that these cells might represent
the rat homologue of murine B-1 cells. This study
shows that neonatal MZ-B cells have the same
phenotype. We consider it, however, as unlikely that the
sIgM
highCD45R
lowHIS57
highCD90
int B cells in neonatal
rat spleen are in fact, B-1 cells, because (i) CD90
expression levels on neonatal sIgM
highCD45R
low
HIS57
high B cells gradually diminish with age and
(ii) besides the sIgM
highCD45R
lowHIS57
highCD90
int cells,
there are no substantial numbers of sIgM
highCD45R
low
HIS57
highCD90
neg cells (i.e. the phenotype of adult MZ-B
cells), even not at time points that MZs are well
developed. Whether the peritoneal sIgM
highCD45R
low
HIS57
highCD90
int B cells in rat ! SCID mouse chimeras
are indeed the rat homologue of murine B-1 cells still
remains to be resolved.
MATERIALS AND METHODS
Animals and Flow Cytometry
Pregnant female and adult male PVG rats (PVG/OlaHsd)
were obtained from Harlan Netherlands, Horst, The
Netherlands. Male rats were obtained at 10 weeks of age
and killed at 5-months of age. Rats were housed at the
Central Animal Facility of the Faculty of Medical Sciences
(UniversityofGroningen,Groningen,TheNetherlands)and
reared under pathogen free (SPF) conditions. Spleen and
bone marrow cell-suspensions were prepared as described
before (Dammers et al., 1999). Cells were stained for ﬂow
cytometry by a combination of the following FITC-
conjugated, PE-conjugated or biotinylated mouse anti-rat
mAbs: HIS40 (anti-IgM) (Kroese et al.,1 9 9 0 ) ,M a R D 3
(anti-IgD; kind gift from Dr. H. Bazin, University of
Louvain, Brussels, Belgium), HIS57 (Pharmingen, San
Diego,CA)(Dammersetal.,1999),OX-7orHIS51(CD90;
Pharmingen), HIS24 (CD45R (B220); Pharmingen), and
HIS50 (CD24, heat-stable antigen) (Hermans et al.,1 9 9 7 ) .
Biotinylated mAbs were revealed by streptavidin-
allophycocyanin or streptavidin-Cy-Chrome (Pharmingen).
FlowJo software (version 3.6; Tree Star, San Carlos, CA)
was used for ﬂow cytometry data analysis.
Immunohistology of Splenic Tissue Sections
Splenic tissuewas snap frozen in isopentane at 2808C and
stored at 2808C. Indirect immunoperoxidase labeling of
spleen sections was performed according to Zandvoort
et al., 2001b. The following mAbs were used for indirect
immunoperoxidase labeling: HIS8 (Igk), HIS24 (CD45R),
HIS40(IgM)(Kroeseetal.,1990),HIS57(Dammersetal.,
1999), MaRD3 (IgD; kind gift from Dr. H. Bazin,
University of Louvain, Brussels, Belgium), ER-04 (CD90)
(Vaessen et al., 1985), and R73 (TCRab) (Hu ¨nig et al.,
1989). For indirect immunoﬂuorescent labeling of spleen
sections, cryostat sections of 5mm were used. Sections
were air-dried and ﬁxed in acetone (2208C) for 10min.
Slides were incubated for 1h in phosphate buffered saline
(PBS) containing appropriately diluted HIS24 (IgG2b)
and HIS57 (IgG1) mAbs. After rinsing for 3 £ 5min with
PBS, the slides were incubated for 30min in PBS
containing 3% (v/v) normal rat serum and appropriately
diluted goat anti-mouse IgG2b (FITC) and goat anti-
mouse IgG1 (TRITC) polyclonal antiserum (Southern
Biotechnology Associates, Birmingham, AL). After
rinsing for 3 £ 5min with PBS, sections were counter-
stained using 40, 6-diamidino-2-phenylindole, dihy-
drochloride (DAPI; Molecular Probes, Eugene, OR)
according to the manufacturers recommendations, and
subsequently embedded in Vectashield H-1000 mounting
medium (Vector Laboratories, Burlingame, CA).
Immunoﬂuorescent staining was revealed on a Leica
TCS SP2 Confocal Microscope using Leica imaging
software (version 2.0; Leica Microsystems, Wetzlar,
Germany).
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